ATW SPAC Management’s Estrella Immunopharma, Inc. Warrant ESLAW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.59K | Hold |
183,099
| – | – | 0.01% | 105 |
|
|
2025
Q1 | $16.2K | Hold |
183,099
| – | – | 0.03% | 77 |
|
|
2024
Q4 | $12.7K | Hold |
183,099
| – | – | 0.02% | 89 |
|
|
2024
Q3 | $16.2K | Buy |
+183,099
| New | +$16.2K | 0.02% | 99 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 100 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 100 |
|
|
2023
Q4 | – | Sell |
-183,099
| Closed | -$44K | – | 102 |
|
|
2023
Q3 | $44K | Sell |
183,099
-11,901
| -6% | -$2.86K | 0.06% | 75 |
|
|
2023
Q2 | $10.2K | Hold |
195,000
| – | – | 0.01% | 159 |
|
|
2023
Q1 | $21.6K | Hold |
195,000
| – | – | 0.01% | 119 |
|
|
2022
Q4 | $10.1K | Hold |
195,000
| – | – | ﹤0.01% | 161 |
|
|
2022
Q3 | $13K | Hold |
195,000
| – | – | ﹤0.01% | 263 |
|
|
2022
Q2 | $49K | Hold |
195,000
| – | – | 0.01% | 210 |
|
|
2022
Q1 | $44 | Hold |
195,000
| – | – | 0.01% | 240 |
|
|
2021
Q4 | $1.93M | Hold |
195,000
| – | – | 0.3% | 110 |
|
|
2021
Q3 | $1.93M | Buy |
+195,000
| New | +$1.93M | 0.36% | 80 |
|